Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENCORE1 efavirenz pharmacokinetics sub-study in HIV infection
ACTRN12612000263897Phase 3Active, not recruiting
- Sponsor
- The Kirby Institute
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by The Kirby Institute. Started Dec 2011; status: active, not recruiting.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ACTRN12612000263897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000263897.